The rising number of acute stroke patients has fuelled the growth of the global acute ischemic stroke diagnosis and treatment market. The global acute ischemic stroke diagnosis and treatment market was worth US$1.2 billion in 2013 and is expected to grow at a CAGR of 6.3% during the period from 2014 to 2020 and reach a valuation of US$1.9 billion by the end of 2020.
An acute ischemic stroke stops the blood supply to a part of the brain as a result of blood clots in blood vessels. Ischemic strokes are more common compared to hemorrhagic strokes. The ever-increasing number of patients suffering from acute strokes has boosted the growth of the global acute ischemic stroke diagnosis and treatment market.
Get a Sample of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1799
Advanced surgical and diagnostic devices have increased the success rate of surgeries and shortened the recovery period, which has augmented the growth of the global acute ischemic stroke diagnosis and treatment market. However, the high cost of the surgical procedures and medications might hamper the growth of the overall market. Due to the large population pool in the Asia Pacific region, especially in countries such as Japan, China, South Korea, and India, the acute ischemic stroke treatment market has a huge opportunity to grow in this region.
On the basis of diagnostic type, the global acute ischemic stroke diagnosis and treatment market has been segmented into cerebral angiography, ultrasound, nuclear imaging, computed tomography (CT), magnetic resonance imaging (MRI), and others. In 2013, computed tomography accounted for the largest share of the overall market, owing to its efficient detection of lesions in the body. Also, it is highly recommended and preferred by doctors across the globe for the diagnosis of ischemic stroke. However, the steep cost and technological complexities associated with computed tomography might restrict the growth of this segment in the period between 2014 and 2020.
Depending upon the surgery type, the global acute ischemic stroke diagnosis and treatment market has been categorized into three major surgical procedures: carotid endarterectomy, endovascular mechanical thrombectomy, and angioplasty. In carotid endarterectomy, the surgeon removes the layers of fatty deposits blocking one of the two carotid arteries that provide blood to the brain. The high success rate and short treatment duration have made this surgical procedure the most preferred for acute ischemic stroke. However, the side effects of the surgery, such as possible reblockage of the artery (since it doesn’t address the core issue) and nerve injury will restrict the growth of this surgical segment during the forecast period.
Globally, the acute ischemic stroke diagnosis and treatment market has been divided into Europe, North America, Asia Pacific, and Rest of the World. North America emerged as the leading region of the overall market in 2013. According to the Centers for Disease Control and Prevention, about 87% of all strokes in the U.S. are ischemic strokes. Though North America has historically driven the demand from the acute ischemic stroke diagnosis and treatment market, the region will play spoilsport in the growth of the global market during the forecast period due to the stringent regulations posed by the FDA regarding medical device treatment for stroke. Europe followed North America as the second largest region in the market in 2013.
In the forecast horizon, Asia Pacific is expected to show the fastest growth in the acute ischemic stroke diagnosis and treatment market because of its rising population base. However, in Asian countries, oral anticoagulation with Vitamin K antagonists such as Warfarin is often prescribed as a preventive measure by the doctors. This will hamper the growth of the market in this region.
The key players of the acute ischemic stroke diagnosis and treatment market include Covidien, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, GE Healthcare, and Stryker Corporation.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453